Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
7.54
-0.53 (-6.57%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $326.29 million as of March 20, 2026. Its market cap has increased by 2,712.84% in one year.
Market Cap
326.29M
Enterprise Value
303.99M
1-Year Change
2,712.84%
Ranking
Category
Stock Price
$7.54
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $326.29M, an increase of 195.02%. That is a compound annual growth rate of 9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 326.30M | 1,061.21% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 347.74M |
| Ovid Therapeutics | 345.51M |
| XOMA Royalty | 341.81M |
| Greenwich LifeSciences | 333.89M |
| LENZ Therapeutics | 327.92M |
| PepGen | 324.84M |
| Immuneering | 324.56M |
| Palisade Bio | 313.52M |